Media Trust Score100%

Bluejay Therapeutics raises $41 million in Series B round to drive clinical trials in chronic

SAN MATEO, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) — Bluejay Therapeutics announced today that it has closed a $41 million Series B round of …

  • You already voted!
  • Read More